1.
Propyl isomerase Pin1 promotes APP protein turnover by inhibiting GSK3β kinase activity: A novel mechanism for Pin1 to protect against Alzheimer's disease.
Ma SL, Pastorino L, Zhou XZ, Lu KP.
J Biol Chem. 2011 Dec 19. [Epub ahead of print]
PMID: 22184106 [PubMed - as supplied by publisher]
Related citations
2.
Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia.
Hassan A, Parisi JE, Josephs KA.
Neurocase. 2011 Dec 20. [Epub ahead of print]
PMID: 22181323 [PubMed - as supplied by publisher]
Related citations
3.
Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice.
Bi M, Ittner A, Ke YD, Götz J, Ittner LM.
PLoS One. 2011;6(12):e26860. Epub 2011 Dec 8.
PMID: 22174735 [PubMed - in process] Free PMC Article
Related citations
4.
Linking Amyloid-β and Tau: Amyloid-β Induced Synaptic Dysfunction via Local Wreckage of the Neuronal Cytoskeleton.
Zempel H, Mandelkow EM.
Neurodegener Dis. 2011 Dec 7. [Epub ahead of print]
PMID: 22156588 [PubMed - as supplied by publisher]
Related citations
5.
Enriched odor exposure decrease tau phosphorylation in the rat hippocampus and cortex.
Liao K, Zhu LQ.
Neurosci Lett. 2011 Dec 2. [Epub ahead of print]
PMID: 22155098 [PubMed - as supplied by publisher]
Related citations
6.
Rac1b Increases with Progressive Tau Pathology within Cholinergic Nucleus Basalis Neurons in Alzheimer's Disease.
Perez SE, Getova DP, He B, Counts SE, Geula C, Desire L, Coutadeur S, Peillon H, Ginsberg SD, Mufson EJ.
Am J Pathol. 2011 Dec 3. [Epub ahead of print]
PMID: 22142809 [PubMed - as supplied by publisher]
Related citations
7.
Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease.
Salminen A, Kaarniranta K, Haapasalo A, Hiltunen M, Soininen H, Alafuzoff I.
Prog Neurobiol. 2011 Nov 22;96(1):87-95. [Epub ahead of print]
PMID: 22138392 [PubMed - as supplied by publisher]
Related citations
8.
Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology.
Glass DJ, Arnold SE.
Alzheimers Dement. 2011 Nov 30. [Epub ahead of print]
PMID: 22137143 [PubMed - as supplied by publisher]
Related citations
9.
Dietary intake of cottonseed toxins is hypothesized to be a partial cause of Alzheimer's disorder.
Semon B.
Med Hypotheses. 2011 Dec 1. [Epub ahead of print]
PMID: 22136946 [PubMed - as supplied by publisher]
Related citations
10.
Alzheimer's Disease: Redox Dysregulation as a Common Denominator for Diverse Pathogenic Mechanisms.
von Bernhardi R, Eugenin J.
Antioxid Redox Signal. 2011 Nov 28. [Epub ahead of print]
PMID: 22122400 [PubMed - as supplied by publisher]
Related citations
11.
Insights into Mitochondrial Dysfunction: Aging, Amyloid-β and Tau - a deleterious trio.
Schmitt K, Grimm A, Kazmierczak A, Strosznajder JB, Götz J, Eckert A.
Antioxid Redox Signal. 2011 Nov 27. [Epub ahead of print]
PMID: 22117646 [PubMed - as supplied by publisher]
Related citations
12.
Tangle evolution linked to differential 3- and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies.
Uchihara T, Hara M, Nakamura A, Hirokawa K.
Histochem Cell Biol. 2011 Nov 25. [Epub ahead of print]
PMID: 22116524 [PubMed - as supplied by publisher]
Related citations
13.
The Interface between Cytoskeletal Aberrations and Mitochondrial Dysfunction in Alzheimer's Disease and Related Disorders.
Kang DE, Roh SE, Woo JA, Liu T, Bu JH, Jung AR, Lim Y.
Exp Neurobiol. 2011 Jun;20(2):67-80. Epub 2011 Jun 30.
PMID: 22110363 [PubMed] Free PMC Article
Related citations
14.
Drug development for Alzheimer's disease: recent progress.
Ji W, Ha I.
Exp Neurobiol. 2010 Dec;19(3):120-31. Epub 2010 Dec 31.
PMID: 22110351 [PubMed] Free PMC Article
Related citations
15.
Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1.
Platt B, Drever B, Koss D, Stoppelkamp S, Jyoti A, Plano A, Utan A, Merrick G, Ryan D, Melis V, Wan H, Mingarelli M, Porcu E, Scrocchi L, Welch A, Riedel G.
PLoS One. 2011;6(11):e27068. Epub 2011 Nov 11.
PMID: 22096518 [PubMed - in process] Free PMC Article
Related citations
16.
Targeting Post-translational Modifications on Tau as a Therapeutic Strategy for Alzheimer's Disease.
Marcus JN, Schachter J.
J Neurogenet. 2011 Dec;25(4):127-33.
PMID: 22091726 [PubMed - in process]
Related citations
17.
Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging.
Maarouf CL, Daugs ID, Kokjohn TA, Walker DG, Hunter JM, Kruchowsky JC, Woltjer R, Kaye J, Castaño EM, Sabbagh MN, Beach TG, Roher AE.
PLoS One. 2011;6(11):e27291. Epub 2011 Nov 7.
PMID: 22087282 [PubMed - in process] Free PMC Article
Related citations
18.
Cell Cycle Proteins in Brain in Mild Cognitive Impairment: Insights into Progression to Alzheimer Disease.
Keeney JT, Swomley AM, Harris JL, Fiorini A, Mitov MI, Perluigi M, Sultana R, Butterfield DA.
Neurotox Res. 2011 Nov 15. [Epub ahead of print]
PMID: 22083458 [PubMed - as supplied by publisher]
Related citations
19.
Cooperative folding of tau peptide by coordination of group IIB metal cations during heparin-induced aggregation.
Yang DJ, Shi S, Yao TM, Ji LN.
Biometals. 2011 Nov 15. [Epub ahead of print]
PMID: 22083130 [PubMed - as supplied by publisher]
Related citations
20.
Granulovacuolar degenerations appear in relation to hippocampal phosphorylated tau accumulation in various neurodegenerative disorders.
Yamazaki Y, Matsubara T, Takahashi T, Kurashige T, Dohi E, Hiji M, Nagano Y, Yamawaki T, Matsumoto M.
PLoS One. 2011;6(11):e26996. Epub 2011 Nov 3.
PMID: 22073234 [PubMed - in process]
No comments:
Post a Comment